Nardilysin, ADAM10, and Alzheimer's disease: of mice and men
Authors:
- Hans-Gert BernsteinHBHans-Gert Bernstein
- Johann SteinerJSJohann Steiner
- Bernhard BogertsBBBernhard Bogerts
- Rolf StrickerRSRolf Stricker
- Georg ReiserGRGeorg Reiser
- 1 March 2014
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 35 (3) , e1
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse modelNeurobiology of Aging, 2014
- Nardilysin in human brain diseases: both friend and foeAmino Acids, 2013
- P2‐319: Nardilysin prevents amyloid plaque formation by enhancing alpha‐secretase activity in vivoAlzheimer's & Dementia, 2011
- Reduced neuronal co-localisation of nardilysin and the putative α-secretases ADAM10 and ADAM17 in Alzheimer’s disease and Down syndrome brainsAGE, 2008